Pituitary Stalk Interruption Syndrome
1 clinical trials · Condition
◉ Watch Pituitary Stalk Interruption Syndrome
| Record | Firm | Date |
|---|---|---|
| A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756) (NCT06760546) | Rhythm Pharmaceuticals, Inc. | 2025-09-23 |
Track Pituitary Stalk Interruption Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.